The immune system's involvement in obesity-driven type 2 diabetes

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 436-442

  Shu, Chengyi Jenny ^a   Benoist, Christophe ^a   Mathis, Diane ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adipose tissue; Inflammation; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; CELLULAR IMMUNITY; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INSULIN RESISTANCE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MICE; OBESITY;

EID: 84874249393     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.12.001     Document Type: Review

References (93)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. Journal of Clinical Investigation 2006, 116:1793-1801.
3. Sabio G., Das M., Mora A., Zhang Z., Jun J.Y., Ko H.J., et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008, 322:1539-1543.
4. Qi L., Saberi M., Zmuda E., Wang Y., Altarejos J., Zhang X., et al. Adipocyte CREB promotes insulin resistance in obesity. Cell Metabolism 2009, 9:277-286.
5. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 2005, 11:191-198.
6. Sabio G., Kennedy N.J., Cavanagh-Kyros J., Jung D.Y., Ko H.J., Ong H., et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Molecular and Cellular Biology 2010, 30:106-115.
7. Gastaldelli A., Miyazaki Y., Pettiti M., Matsuda M., Mahankali S., Santini E., et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2002, 87:5098-5103.
8. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Reviews 2010, 11:11-18.
9. Macotela Y., Emanuelli B., Mori M.A., Gesta S., Schulz T.J., Tseng Y.H., et al. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 2012, 61:1691-1699.
10. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
11. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation 1995, 95:2409-2415.
12. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
13. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine 2005, 11:183-190.
14. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metabolism 2007, 6:386-397.
15. Tuncman G., Hirosumi J., Solinas G., Chang L., Karin M., Hotamisligil G.S. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:10741-10746.
16. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
17. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
18. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005, 46:2347-2355.
19. Murano I., Barbatelli G., Parisani V., Latini C., Muzzonigro G., Castellucci M., et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. Journal of Lipid Research 2008, 49:1562-1568.
20. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
21. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003, 112:1821-1830.
22. Gordon S. Alternative activation of macrophages. Nature Reviews Immunology 2003, 3:23-35.
23. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. Journal of Biological Chemistry 2007, 282:35279-35292.
24. Prieur X., Mok C.Y., Velagapudi V.R., Nunez V., Fuentes L., Montaner D., et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011, 60:797-809.
25. Patsouris D., Li P.P., Thapar D., Chapman J., Olefsky J.M., Neels J.G. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metabolism 2008, 8:301-309.
26. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58:2574-2582.
27. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007, 117:175-184.
28. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
29. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Gyori G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. International Journal of Obesity (2005) 2007, 31:1420-1428.
30. Bourlier V., Zakaroff-Girard A., Miranville A., De B.S., Maumus M., Sengenes C., et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008, 117:806-815.
31. Shaul M.E., Bennett G., Strissel K.J., Greenberg A.S., Obin M.S. Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 2010, 59:1171-1181.
32. Herrero L., Shapiro H., Nayer A., Lee J., Shoelson S.E. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:240-245.
33. Miller J.C., Brown B.D., Shay T., Gautier E.L., Jojic V., Cohain A., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nature Immunology 2012, 13:888-899.
34. Mauer J., Chaurasia B., Plum L., Quast T., Hampel B., Bluher M., et al. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genetics 2010, 6:e1000938.
35. Furuhashi M., Fucho R., Gorgun C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. Journal of Clinical Investigation 2008, 118:2640-2650.
36. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006, 116:3015-3025.
37. Saberi M., Woods N.B., de L.C., Schenk S., Lu J.C., Bandyopadhyay G., et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metabolism 2009, 10:419-429.
38. Neels J.G., Badeanlou L., Hester K.D., Samad F. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. Journal of Biological Chemistry 2009, 284:20692-20698.
39. Feral C.C., Neels J.G., Kummer C., Slepak M., Olefsky J.M., Ginsberg M.H. Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity. Diabetes 2008, 57:1842-1851.
40. Lesniewski L.A., Hosch S.E., Neels J.G., de L.C., Pashmforoush M., Lumeng C.N., et al. Bone marrow-specific Cap gene deletion protects against high-fat diet-induced insulin resistance. Nature Medicine 2007, 13:455-462.
41. Liao X., Sharma N., Kapadia F., Zhou G., Lu Y., Hong H., et al. Kruppel-like factor 4 regulates macrophage polarization. Journal of Clinical Investigation 2011, 121:2736-2749.
42. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
43. Kowalski G.M., Nicholls H.T., Risis S., Watson N.K., Kanellakis P., Bruce C.R., et al. Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice. Diabetologia 2011, 54:888-899.
44. Lee S.J., Kim J.Y., Nogueiras R., Linares J.F., Perez-Tilve D., Jung D.Y., et al. PKCzeta-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance. Cell Metabolism 2010, 12:65-77.
45. Miyazaki T., Hirokami Y., Matsuhashi N., Takatsuka H., Naito M. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. Journal of Experimental Medicine 1999, 189:413-422.
46. Kurokawa J., Arai S., Nakashima K., Nagano H., Nishijima A., Miyata K., et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metabolism 2010, 11:479-492.
47. Kurokawa J., Nagano H., Ohara O., Kubota N., Kadowaki T., Arai S., et al. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12072-12077.
48. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature Reviews Immunology 2010, 10:365-376.
49. Hevener A.L., Olefsky J.M., Reichart D., Nguyen M.T., Bandyopadyhay G., Leung H.Y., et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. Journal of Clinical Investigation 2007, 117:1658-1669.
50. Odegaard J.I., Ricardo-Gonzalez R.R., Red E.A., Vats D., Morel C.R., Goforth M.H., et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metabolism 2008, 7:496-507.
51. Sachithanandan N., Graham K.L., Galic S., Honeyman J.E., Fynch S.L., Hewitt K.A., et al. Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance. Diabetes 2011, 60:2023-2031.
52. Stienstra R., Joosten L.A., Koenen T., van T.B., van Diepen J.A., van den Berg S.A., et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metabolism 2010, 12:593-605.
53. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine 2011, 17:179-188.
54. Boden G. Interaction between free fatty acids and glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2002, 5:545-549.
55. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature Immunology 2011, 12:408-415.
56. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nature Immunology 2010, 11:897-904.
57. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
58. Rajamaki K., Lappalainen J., Oorni K., Valimaki E., Matikainen S., Kovanen P.T., et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 2010, 5:e11765.
59. So A., Thorens B. Uric acid transport and disease. Journal of Clinical Investigation 2010, 120:1791-1799.
60. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Molecular and Cellular Biology 2009, 29:4467-4483.
61. Strissel K.J., Stancheva Z., MIYOSHI H., Perfield J.W., DeFuria J., Jick Z., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56:2910-2918.
62. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
63. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
64. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nature Medicine 2009, 15:940-945.
65. Rodewald H.R., Feyerabend T.B. Widespread immunological functions of mast cells: fact or fiction. Immunity 2012, 37:13-24.
66. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
67. Wu H., Ghosh S., Perrard X.D., Feng L., Garcia G.E., Perrard J.L., et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115:1029-1038.
68. Madani R., Karastergiou K., Ogston N.C., Miheisi N., Bhome R., Haloob N., et al. RANTES release by human adipose tissue in vivo and evidence for depot-specific differences. American Journal of Physiology. Endocrinology and Metabolism 2009, 296:E1262-E1268.
69. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Medicine 2009, 15:914-920.
70. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 2009, 15:930-939.
71. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nature Medicine 2009, 15:921-929.
72. Cipolletta D., Kolodin D., Benoist C., Mathis D. Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+T cells that impacts organismal metabolism. Seminars in Immunology 2011, 23:431-437.
73. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. Journal of Immunology 2010, 185:1836-1845.
74. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010, 18:1918-1925.
75. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circulation Research 2008, 103:467-476.
76. Pacifico L., Di R.L., Anania C., Osborn J.F., Ippoliti F., Schiavo E., et al. Increased T-helper interferon-gamma-secreting cells in obese children. European Journal of Endocrinology/European Federation of Endocrine Societies 2006, 154:691-697.
77. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994, 1:553-562.
78. Davidson N.J., Leach M.W., Fort M.M., Thompson-Snipes L., Kuhn R., Muller W., et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. Journal of Experimental Medicine 1996, 184:241-251.
79. Wang Y., Souabni A., Flavell R.A., Wan Y.Y. An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo. Journal of Immunology 2010, 185:5983-5992.
80. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nature Reviews Immunology 2007, 7:585-598.
81. Ilan Y., Maron R., Tukpah A.M., Maioli T.U., Murugaiyan G., Yang K., et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:9765-9770.
82. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nature Medicine 2011, 17:610-617.
83. Ngo V.N., Cornall R.J., Cyster J.G. Splenic T zone development is B cell dependent. Journal of Experimental Medicine 2001, 194:1649-1660.
84. Baumgarth N., Jager G.C., Herman O.C., Herzenberg L.A. CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:4766-4771.
85. Linton P.J., Harbertson J., Bradley L.M. A critical role for B cells in the development of memory CD4 cells. Journal of Immunology 2000, 165:5558-5565.
86. Van K.L. NKT cells: T lymphocytes with innate effector functions. Current Opinion in Immunology 2007, 19:354-364.
87. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nature Immunology 2010, 11:197-206.
88. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
89. Ohmura K., Ishimori N., Ohmura Y., Tokuhara S., Nozawa A., Horii S., et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:193-199.
90. Satoh M., Andoh Y., Clingan C.S., Ogura H., Fujii S., Eshima K., et al. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS ONE 2012, 7:e30568.
91. Kotas M.E., Lee H.Y., Gillum M.P., Annicelli C., Guigni B.A., Shulman G.I., et al. Impact of CD1d deficiency on metabolism. PLoS ONE 2011, 6:e25478.
92. Mantell B.S., Stefanovic-Racic M., Yang X., Dedousis N., Sipula I.J., O'Doherty R.M. Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS ONE 2011, 6:e19831.
93. Ji Y., Sun S., Xu A., Bhargava P., Yang L., Lam K.S., et al. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. Journal of Biological Chemistry 2012, 287:13561-13571.